SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934




Date of Report (date of earliest event reported)   NOVEMBER 14, 2002
                                                   -----------------

                 HEALTH & NUTRITION SYSTEMS INTERNATIONAL, INC.
             (Exact name of registrant as specified in its charter)




                                     FLORIDA
- --------------------------------------------------------------------------------
                 (State or other jurisdiction of incorporation)



           0-29245                                      65-0452156
           -------                                      ----------
   (Commission File Number)                 (IRS Employer Identification No.)


          3750 Investment Lane, Suite 5, West Palm Beach, Florida 33407
- --------------------------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)



Registrant's telephone number, including area code    (561) 863-8446
                                                     ----------------


                                       N/A
- --------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)



ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS --------------------------------- (c) Exhibits: EXHIBIT NUMBER DESCRIPTION ------ ----------- 99.1 Press Release dated November 14, 2002. ITEM 9. REGULATION FD DISCLOSURE ------------------------ On November 14, 2002, Health & Nutrition Systems International, Inc. issued a press release announcing its operating results for the third quarter and nine months ended September 30, 2002. The press release is attached as Exhibit 99.1 and incorporated by reference. 2

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTH & NUTRITION SYSTEMS INTERNATIONAL, INC. By: /s/ Chris Tisi ------------------------------------------ Chris Tisi, Interim Chairman of the Board, Dated: November 15, 2002 Chief Executive Officer and President 3

                                                                    EXHIBIT 99.1
                                [GRAPHIC OMITTED]

For more information, contact:
At the Company:                                               Media Inquiries:
Mona Lalla                                                    Christopher Tisi
Director of Operations                                        President/CEO
PH. (561) -863-8446                                           PH# (561) 863-8446


  HEALTH & NUTRITION SYSTEMS INTERNATIONAL INC. ANNOUNCES THIRD QUARTER RESULTS

FOR IMMEDIATE RELEASE:

WEST PALM BEACH, FL, NOVEMBER 14, 2002, - Health & Nutrition Systems
International Inc. (OTCBB: HNNS) today announced its operating results for the
third quarter.

Net sales for the three months ended September 30, 2002 were $1,031,982, a
decrease of $409,549 or 28%, as compared to net sales of $1,441,531 for the
three months ended September 30, 2001. Net sales for the nine months ended
September 30, 2002 were $3,300,697, a decrease of $945,562 or 22%, as compared
to net sales of $4,247,259 for the nine months ended September 30, 2001. The
decrease was primarily due to a general decline in the market for nutritional
supplements.

Net loss from operations was $(26,493) for the three months ended September 30,
2002, compared to a net profit from operations of $16,900 for the three months
ended September 30, 2001. Net loss was $(94,834) or $(0.03) per share for the
three months ended September 30, 2002, as compared to a net profit of $11,178 or
$0.00 per share for the three months ended September 30, 2001. Net profit from
operations was $166,119 for the nine months ended September 30, 2002, as
compared to a net loss from operations of $(439,365) for the nine months ended
September 30, 2001. Net profit was $84,399 or $0.02 per share for the nine
months ended September 30, 2002, as compared to a net loss of $(415,160) or
$(0.11) per share for the nine months ended September 30, 2001. The decrease in
profit for the three months ended September 30, 2002 was due to the decrease in
sales and the increase in profit for the nine months ended September 30, 2002
was primarily due to a planned decrease in operating expenses.

HNS develops and markets weight management products in over 25,000 health, food
and drug store locations. The Company's products can be found in CVS, GNC,
Eckerd's, Rite Aid, Target, Vitamin Shoppe, Vitamin World, Walgreens and
Wal-Mart. The Company's HNS Direct division distributes to independent health
food stores, gyms and pharmacies. For more information, visit:
http://www.hnsglobal.com/.

Detailed results from this quarter can be obtained at www.freeedgar.com.

This news release contains forward-looking statements, as that term is defined
in the Private Securities Litigation Reform Act of 1995 and is subject to the
safe harbor created by that act. These forward-looking statements concern the
Company's operations, economic performance and financial condition and are based
largely on the Company's beliefs and expectations. These statements involve
known and unknown risks, uncertainties and other factors that may cause actual
results to be materially different from any future results expressed or implied
by such forward-looking statements. Such factors and risks include, among
others, the factors described in the Company's filing with the Securities and
Exchange Commission, the recent terrorist attacks on the United States, possible
responses by the U.S. government, general economic conditions, consumer
confidence and changes in consumer preference, introduction of products that
compete with the Company's products, and the availability and deployment of
capital. Finally, recent government action and the surrounding publicity
regarding ephedra-containing products may make it difficult for us to obtain and
maintain product liability insurance for our products containing ephedra at
current premiums. Certain of these factors and risks, as well as other risks and
uncertainties are stated in more detail in the Company's annual report on Form
10-KSB. These forward-looking statements are made as of the date of this press
release, and the Company assumes no obligation to update the forward-looking
statements or to update the reasons why the actual results could differ from
those projected in the forward- looking statements.